U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C12H15NO3
Molecular Weight 221.2524
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of HYDROCOTARNINE

SMILES

COC1=C2OCOC2=CC3=C1CN(C)CC3

InChI

InChIKey=XXANNZJIZQTCBP-UHFFFAOYSA-N
InChI=1S/C12H15NO3/c1-13-4-3-8-5-10-12(16-7-15-10)11(14-2)9(8)6-13/h5H,3-4,6-7H2,1-2H3

HIDE SMILES / InChI

Description
Curator's Comment: description was created based on several sources, including: https://www.ncbi.nlm.nih.gov/pubmed/19252340

Hydrocotarnine is a crystalline alkaloid, obtained from opium and also formed by the reduction of cotarnine. It is a non-narcotic opium alkaloid. Hydrocotarnine is supposed to potentiate the analgesic effect of oxycodone with unknown mechanism.

CNS Activity

Curator's Comment: The tests were performed at different time periods (5, 15, 45 and 120 min) after male and female Wistar rats were treated with seized heroin. Seized heroin contained a mixture of opiate alkaloids, including hydrocotarnine. Opiate alkaloids were quantitatively determined in brain regions known for their high concentration of µ-opiate receptors: cortex, brainstem, amygdala and basal ganglia. Human data not available.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
18.4 µM [IC50]
6.63 µM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Compound injection of oxycodone and hydrocotarnine is effective for cancer pain treatment
PubMed

PubMed

TitleDatePubMed
Patents

Sample Use Guides

injections of oxycodone and hydrocotarnine contains 8 mg of oxycodone hydrochloride and 2 mg of hydrocotarnine hydrochloride.
Route of Administration: Other
Hydrocotarnine (0.000388–38.8 mM) did not induce a significant change in the metabolic activities of CYP2C9, 2C19, and 2E1. Although weak inhibitory effects were observed on CYP3A4 and 2D6, the inhibition rate was less than 50% at the concentrations below 3.88 mM.
Name Type Language
HYDROCOTARNINE
MI   WHO-DD  
Common Name English
8-METHOXY-5,6-METHYLENEDIOXY-2-METHYL-1,2,3,4-TETRAHYDROISOQUINOLINE
Systematic Name English
Hydrocotarnine [WHO-DD]
Common Name English
HYDROCOTARNINE [MI]
Common Name English
5,6,7,8-TETRAHYDRO-4-METHOXY-6-METHYL-1,3-DIOXOLO(4,5-G)ISOQUINOLINE
Systematic Name English
1,3-DIOXOLO(4,5-G)ISOQUINOLINE, 5,6,7,8-TETRAHYDRO-4-METHOXY-6-METHYL-
Systematic Name English
Code System Code Type Description
FDA UNII
G22L6JNE61
Created by admin on Fri Dec 15 17:24:23 GMT 2023 , Edited by admin on Fri Dec 15 17:24:23 GMT 2023
PRIMARY
EPA CompTox
DTXSID60203535
Created by admin on Fri Dec 15 17:24:23 GMT 2023 , Edited by admin on Fri Dec 15 17:24:23 GMT 2023
PRIMARY
SMS_ID
100000175458
Created by admin on Fri Dec 15 17:24:23 GMT 2023 , Edited by admin on Fri Dec 15 17:24:23 GMT 2023
PRIMARY
MESH
C024594
Created by admin on Fri Dec 15 17:24:23 GMT 2023 , Edited by admin on Fri Dec 15 17:24:23 GMT 2023
PRIMARY
CAS
550-10-7
Created by admin on Fri Dec 15 17:24:23 GMT 2023 , Edited by admin on Fri Dec 15 17:24:23 GMT 2023
PRIMARY
PUBCHEM
3646
Created by admin on Fri Dec 15 17:24:23 GMT 2023 , Edited by admin on Fri Dec 15 17:24:23 GMT 2023
PRIMARY
MERCK INDEX
m6095
Created by admin on Fri Dec 15 17:24:23 GMT 2023 , Edited by admin on Fri Dec 15 17:24:23 GMT 2023
PRIMARY Merck Index
ECHA (EC/EINECS)
208-978-2
Created by admin on Fri Dec 15 17:24:23 GMT 2023 , Edited by admin on Fri Dec 15 17:24:23 GMT 2023
PRIMARY